Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in Canada for addressing Attention-Deficit/Hyperactivity Disorder in youngsters and adults . This functions as a prodrug, meaning it’s https://sandoz-lisdexamfetamine-771294.humor-blog.com/41852415/lisdexamfetamine-in-this-country-a-detailed-overview